Patent directory · USPTO A61K / A61P
Patents matching “Alnylam Pharmaceuticals, Inc.”
376 pharma patents match "Alnylam Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 376 pharmaceutical patents matching "Alnylam Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9222091
Therapeutic compositions
granted -
US 9212364
Compositions and methods for inhibiting expression of mutant EGFR gene
granted -
US 9206421
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
granted -
US 9198972
Monomers and oligonucleotides comprising cycloaddition adduct(s)
granted -
US 9200281
Conserved HBV and HCV sequences useful for gene silencing
granted -
US 9200282
Compositions and methods for inhibiting expression of an RNA from west nile virus
granted -
US 9198983
Compositions and methods for inhibiting expression of Mylip/Idol gene
granted -
US 9198927
Targeting opposite strand replication intermediates of single-stranded viruses by RNAI
granted -
US 9187746
Dual targeting siRNA agents
granted -
US 9187747
RNAi modulation of ApoB and uses thereof
granted -
US 9175290
Compositions and methods for inhibiting expression of TMPRSS6 gene
granted -
US 9133461
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 9133454
Method and medicament for inhibiting the expression of a given gene
granted -
US 9127277
Methods and compositions for prevention or treatment of RSV infection
granted -
US 9127274
Serpinc1 iRNA compositions and methods of use thereof
granted -
US 9102938
2′ and 5′ modified monomers and oligonucleotides
granted -
US 9101643
Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)
granted -
US 9090895
Compositions and methods for inhibiting expression of the HAMP gene
granted -
US 9074213
Compositions and methods for inhibiting expression of a target gene
granted -
US 9061063
Biodegradable lipids for the delivery of active agents
granted -
US 9062310
Compositions and methods for inhibiting expression of factor VII gene
granted -
US 9057069
Compositions and methods for inhibiting expression of Eg5 gene
granted -
US 9035041
Process for triphosphate oligonucleotide synthesis
granted -
US 9029338
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
granted